GlycoFi.

• Localización: Scientific American, ISSN 0036-8733, Vol. 291, Nº. 6, 2004, págs. 56-56
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Reports on the development of a industrial platform for making protein drugs by GlycoFi. Building on research first conducted at Dartmouth College, GlycoFi is producing sugarcoated human proteins in yeast. Because yeast does not ordinarily have chemical pathways to put the right sugars on proteins, GlycoFi is engineering assembly lines of enzymes from a variety of species. Joint studies were announced with biotechnology leaders Biogen in November 2003 and Eli Lilly in April 2004. The payoff may be better yields, lower production costs and longer-lasting, more potent drugs.